Skip to main content
. 2021 Aug 20;36(2):464–475. doi: 10.1038/s41375-021-01381-4

Fig. 6. 8q24 amplification in CLL patients.

Fig. 6

a Overall survival and b time to treatment analysis of CLL patients with (n = 6) or without (n = 128) 8q24 amplification (blue and red line, respectively). c Overall survival and d time to treatment analysis within patients with unmutated IGHV genes with (n = 5) or without (n = 60) 8q24 amplification.